Karl G. Blume

16.7k citations

162 papers · 10.5k indexed · 3 hit papers · h-index 53

Hematology top 0.05%
- Hematopoietic Stem Cell Transplantation 87
- Acute Myeloid Leukemia Research 25
Transplantation top 0.5%
Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research 16
Immunology top 0.5%
- T-cell and B-cell Immunology 24
- Immune Cell Function and Interaction 23
Oncology top 0.5%
Pathology and Forensic Medicine
- Lymphoma Diagnosis and Treatment 22
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 16
Physiology
- Erythrocyte Function and Pathophysiology 14

Co-authors: Robert S. Negrin Stephen J. Forman Rainer Storb Barry E. Storer Keith Stockerl‐Goldstein Thomas R. Chauncey Frederick R. Appelbaum Ernest Beutler
Cited by: Hematology Transplantation Genetics
Journals: Nature (1 paper)New England Journal of Medicine (6 papers)Proceedings of the National Academy of Sciences (1 paper)
Partner nations: United States Germany Italy

In The Last Decade

Karl G. Blume

161 papers receiving 10.2k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2001 New England Journal of Medicine
1993 New England Journal of Medicine
1977 British Journal of Haematology

Peers

Countries citing papers authored by Karl G. Blume

Since Specialization

Citations

This map shows the geographic impact of Karl G. Blume's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl G. Blume with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl G. Blume more than expected).

Fields of papers citing papers by Karl G. Blume

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl G. Blume. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl G. Blume. The network helps show where Karl G. Blume may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Karl G. Blume, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Karl G. Blume Line = papers co-authored together Karl G. Blume links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Long-Term Outcome of Patients with Metastatic Breast Cancer Treated with High-Dose Chemotherapy and Transplantation of Purified Autologous Hematopoietic Stem Cells Biology of Blood and Marrow Transplantation ·Antonia Müller,Holbrook E. Kohrt,Steven Cha,Ginna G. Laport,Jared Klein,Alice E. Guardino,Laura Johnston,Keith Stockerl‐Goldstein,Elie G. Hanania,Christopher A. Juttner,Karl G. Blume,Robert S. Negrin,Irving L. Weissman,Judith A. Shizuru	2011	28
2	Five-Year Follow-Up of Patients With Advanced Chronic Lymphocytic Leukemia Treated With Allogeneic Hematopoietic Cell Transplantation After Nonmyeloablative Conditioning Journal of Clinical Oncology ·Mohamed L. Sorror,Barry E. Storer,Brenda M. Sandmaier,Michael B. Maris,Judith A. Shizuru,Richard T. Maziarz,Edward Agura,Thomas R. Chauncey,Michael A. Pulsipher,Peter A. McSweeney,James C. Wade,Benedetto Bruno,Amelia Langston,Jerald P. Radich,Dietger Niederwieser,Karl G. Blume,Rainer Storb,David G. Maloney	2008	182
3	Unrelated Donor Granulocyte Colony-Stimulating Factor–Mobilized Peripheral Blood Mononuclear Cell Transplantation after Nonmyeloablative Conditioning: The Effect of Postgrafting Mycophenolate Mofetil Dosing Biology of Blood and Marrow Transplantation ·Michael B. Maris,Brenda M. Sandmaier,Barry E. Storer,David G. Maloney,Judith A. Shizuru,Edward Agura,Constanze Kliem,Michael A. Pulsipher,Richard T. Maziarz,Peter A. McSweeney,James C. Wade,Amelia Langston,Thomas R. Chauncey,Benedetto Bruno,Karl G. Blume,Rainer Storb	2006	75
4	Assessing donor chimerism level among CD3 T, CD4 T, CD8 T, and NK cells predicts subsequent graft rejection, GVHD, and relapse after allogeneic HCT with nonmyeloablative conditioning Biology of Blood and Marrow Transplantation ·F Baron,Rainer Storb,Ted Gooley,Brenda M. Sandmaier,Serina Gisburne,Seung‐Hwan Shin,P. Stroup,Jennifer E. Baker,Mike Maris,David G. Maloney,S Heimfeld,F. Carl Grumet,Thomas R. Chauncey,Karl G. Blume,Michelle Little	2005	7
5	Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia Biology of Blood and Marrow Transplantation ·Vivian G. Oehler,Jerald P. Radich,Barry E. Storer,Karl G. Blume,Thomas R. Chauncey,Reginald A. Clift,David S. Snyder,Stephen J. Forman,Mary E.D. Flowers,Paul J. Martin,Katherine A. Guthrie,Robert S. Negrin,Frederick R. Appelbaum,William Bensinger	2005	43
6	Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML Leukemia ·Fábio R. Kerbauy,Rainer Storb,Ute Hegenbart,Ted Gooley,Judith A. Shizuru,Haifa Kathrin Al‐Ali,Jerald P. Radich,DG Maloney,E.D. Agura,Benedetto Bruno,Elliot Epner,Thomas R. Chauncey,Karl G. Blume,Dietger Niederwieser,Brenda M. Sandmaier	2005	37
7	Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant Biology of Blood and Marrow Transplantation ·Lyle Feinstein,Brenda M. Sandmaier,David G. Maloney,Michael B. Maris,Theodore A. Gooley,Thomas R. Chauncey,Ute Hegenbart,Peter A. McSweeney,Monic J. Stuart,Stephen J. Forman,Edward Agura,Michael A. Pulsipher,Karl G. Blume,Dietger Niederwieser,Rainer Storb	2003	21
8	Intravenous versus oral busulfan as part of a busulfan/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation: Decreased incidence of hepatic venoocclusive disease (HVOD), HVOD-related mortality, and overall 100-day mortality Biology of Blood and Marrow Transplantation ·Ashwin Kashyap,John R. Wingard,Pablo J. Cagnoni,Roy Jones,Stephan Tarantolo,Wendy Hu,Karl G. Blume,Joyce C. Niland,Joycelynne Palmer,William P. Vaughan,Hugo F. Fernández,Richard Champlin,Stephen J. Forman,Börje S. Andersson	2002	172
9	NONMYELOABLATIVE HEMATOPOIETIC STEM CELL TRANSPLANTS (HSCT) FROM HLA-MATCHED RELATED DONORS FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES: CLINICAL RESULTS OF A TBI-BASED CONDITIONING REGIMEN Blood ·Bm Sandmaier,DG Maloney,Ted Gooley,Ute Hegenbart,Judith A. Shizuru,Firoozeh Sahebi,T Chauncey,E.D. Agura,Bénedicte Bruno,Peter A. McSweeney,Stephen J. Forman,Karl G. Blume,D Niederwieser,R Strob	2001	32
10	Improve the Outcome of Autologous Hematopoietic Cell Transplantation! Biology of Blood and Marrow Transplantation ·Karl G. Blume	2001	3
11	Efficacy and toxicity of a CCNU-containing high-dose chemotherapy regimen followed by autologous hematopoietic cell transplantation in relapsed or refractory Hodgkin's disease Biology of Blood and Marrow Transplantation ·Monic J. Stuart,Nelson J. Chao,Sandra J. Horning,Ruby M. Wong,Robert S. Negrin,Laura Johnston,Judith A. Shizuru,Gwynn D. Long,Karl G. Blume,Keith Stockerl‐Goldstein	2001	17
12	Allogeneic stem cell transplantation (BMT) for AML and MDS following i.v. busulfan and cyclophosphamide (i.v. BuCy) Bone Marrow Transplantation ·BS Andersson,James Gajewski,Michèle L. Donato,Sergio Giralt,Victor G. Gian,John R. Wingard,Stefano Tarantolo,Hugo F. Fernández,WW Hu,Karl G. Blume,A. Kashyap,SJ Forman,RE Champlin	2000	34
13	Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma Biology of Blood and Marrow Transplantation ·Laura Johnston,Keith Stockerl‐Goldstein,Wendy Hu,Robert S. Negrin,Richard T. Hoppe,Karl G. Blume,Sandra J. Horning	2000	11
14	Allogeneic Bone Marrow Transplant in Pediatric Patients with High-Risk Hematopoietic Malignancies Early in the Course of Their Disease The American journal of pediatric hematology/oncology ·Michael D. Amylon,John Patrick T.,David S. Snyder,Sarah S. Donaldson,Karl G. Blume,Stephen J. Forman	1997	3
15	High dose etoposide-based myeloablative therapy followed by autologous blood progenitor cell rescue in the treatment of multiple myeloma Cancer ·Gwynn D. Long,Nelson J. Chao,Wendy Hu,Robert S. Negrin,Ruby M. Wong,Karl G. Blume	1996	9
16	Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma. Journal of Clinical Oncology ·Sandra J. Horning,Robert S. Negrin,J. Chao,G D Long,Richard T. Hoppe,Karl G. Blume	1994	68
17	Propagation of large numbers of T cells with natural killer cell markers British Journal of Haematology ·Ingo G.H. Schmidt‐Wolf,Petja Lefterova,Valerie Johnston,D. Huhn,Karl G. Blume,Robert S. Negrin	1994	102
18	EXTENDED FOLLOW-UP IN 212 LONG-TERM ALLOGENEIC BONE MARROW TRANSPLANT SURVIVORS ISSUES OF QUALITY OF LIFE Transplantation ·G. Schmidt,Joyce C. Niland,Stephen J. Forman,FILAR P. FONBUENA,Andrew Dagis,Marcia Grant,Betty Ferrell,TRILLA A. BARR,BARBARA A. STALLBAUM,Nelson J. Chao,Karl G. Blume	1993	78
19	Bone Marrow Transplantation from Histocompatible Sibling Donors for Patients with Acute Lymphoblastic Leukemia Hämatologie und Bluttransfusion ·Karl G. Blume,G. Schmidt,Nelson J. Chao,Stephen J. Forman	1990	8
20	Clinical bone marrow transplantation Churchill Livingstone eBooks ·Karl G. Blume,Lawrence D. Petz	1983	33

About Karl G. Blume

Karl G. Blume is a scholar working on Hematology, Transplantation and Genetics, having authored 162 papers that have together received 10.5k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (87 papers), Acute Myeloid Leukemia Research (25 papers), T-cell and B-cell Immunology (24 papers), Immune Cell Function and Interaction (23 papers), Lymphoma Diagnosis and Treatment (22 papers), Chronic Lymphocytic Leukemia Research (16 papers), Acute Lymphoblastic Leukemia research (16 papers) and Erythrocyte Function and Pathophysiology (14 papers). The work is most often cited by research in Hematology (6.7k citations), Transplantation (618 citations) and Genetics (1.8k citations). Karl G. Blume has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Robert S. Negrin, Stephen J. Forman, Rainer Storb, Barry E. Storer, Keith Stockerl‐Goldstein, Thomas R. Chauncey, Frederick R. Appelbaum, Ernest Beutler, Judith A. Shizuru and Brenda M. Sandmaier. Their work appears in journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact